Business news – Page 65
-
Business
Dow ditches older herbicides
Gowan will acquire Dow’s entire dinitroaniline herbicide portfolio
-
Business
EPA acts to halt approval of Dow’s Enlist Duo herbicide
US environmental agency wants registration of controversial herbicide halted, pending review of new toxicity data
-
NewsUS agencies test less than 1% of chemicals
Only 250 of the 84,000 chemicals registered for commercial use in the US have been tested by government agencies
-
BusinessMerger creates new gases giant
Air Liquide will buy Airgas in a $13 billion deal to become the world’s biggest industrial gases supplier
-
BusinessPfizer and Allergan agree mega-merger
$160 billion deal allows Pfizer to escape US tax system by re-homing in Ireland
-
Business
Drug firms to share chemical compound libraries
AstraZeneca and Sanofi aim to facilitate drug discovery by swapping 210,000 proprietary chemical compounds
-
OpinionEmerging from Babel
Will English ever lose its place as the lingua franca of chemistry, asks Derek Lowe
-
Opinion
Toeing the advertising line
Companies have to tread a little carefully when it comes to advertising prescription drugs
-
BusinessAdvancing animal testing alternatives
Animal rights groups are engaging with researchers and regulators to develop replacement tests and ensure they’re adopted
-
Business
Carbon dioxide leak at US coffee plant prompts federal probe
The Occupational Health and Safety Administration is investigating a fatal incident at a Texas decaffeination plant
-
BusinessBuilding better bottles
Catalytic Technologies wants to replace antimony catalysts in polyester production with safer, more active titanium
-
BusinessViral cancer therapy approved in the US
T-Vec is the first approved oncolytic virus, but its limited treatment scope means it is unlikely to become a blockbuster
-
BusinessPharma kickback claims lead to individual prosecutions
Warner Chilcott and Novartis face large fines for paying doctors to prescribe their drugs
-
Business
AstraZeneca to buy ZS Pharma for ion-balance drugs
$2.7 billion deal anticipates regulatory success for drug candidate under review
-
Business
Samsung to sell chemicals businesses to Lotte
Korean conglomerate Lotte will pay £1.7 billion for stake in Samsung’s chemicals businesses
-
Business
Dow backs off of Kuwaiti joint ventures
EQUATE will acquire MEGlobal as part of Dow’s restructuring of its Kuwaiti joint ventures
-
Business
Shire to buy rare disease specialist Dyax
Deal includes an already-approved drug for angioedema and an experimental antibody treatment
-
Business
Bristol-Myers Squibb to buy Cardioxyl for heart drug
Deal worth up to $2bn gives BMS full rights to Phase II clinical candidate
-
Business
Job cuts at Daiichi, Perrigo and Cabot
Staff reductions aimed at cutting costs or, in Perrigo’s case, fending off a takeover bid